BRIEF-Actelion gets Japanese nod for epoprostenol "ACT"

ZURICH Mon Feb 18, 2013 11:38am EST

Related Topics

ZURICH Feb 18 (Reuters) - Actelion Ltd : * Actelion Pharmaceuticals Ltd : Actelion obtains marketing approval for

epoprostenol "ACT" in Japan

FILED UNDER: